Literature DB >> 2872767

Metabolic interaction between morphine and various benzodiazepines.

G M Pacifici, L L Gustafsson, J Säwe, A Rane.   

Abstract

The interaction between benzodiazepines and the glucuronidation of morphine was studied in vitro and in vivo. All benzodiazepines tested (diazepam, N-desmethyldiazepam, oxazepam, lorazepam, clonazepam, nitrazepam and flunitrazepam) inhibited the glucuronidation of morphine in vitro in rat liver microsomes. Clonazepam was the most and nitrazepam the least powerful inhibitor, reducing the rate of morphine conjugation by 86% and 42% of the control, respectively, at a substrate and inhibitor concentration of 1.5 mM. Rats given a single oral dose of oxazepam (20 mg per kg body weight) one hour prior to an intraperitoneal dose of morphine (10 mg per kg body weight) had a lower morphine glucuronide/morphine concentration ratio in the 24 hour urine portion than control rats without pretreatment with oxazepam. These data indicate that oxazepam inhibits the glucuronidation of morphine in rats in vivo as well as in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872767     DOI: 10.1111/j.1600-0773.1986.tb00103.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  5 in total

Review 1.  Pharmacology of drugs frequently used in ICUs: midazolam and flumazenil.

Authors:  R Amrein; W Hetzel
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Population pharmacokinetics of heroin and its major metabolites.

Authors:  Elisabeth J Rook; Alwin D R Huitema; Wim van den Brink; Jan M van Ree; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  High levels of morphine-6-glucuronide in street heroin addicts.

Authors:  Letizia Antonilli; Federico Semeraro; Carmen Suriano; Luciano Signore; Paolo Nencini
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

4.  Human liver morphine UDP-glucuronyl transferase enantioselectivity and inhibition by opioid congeners and oxazepam.

Authors:  A Wahlström; G M Pacifici; B Lindström; L Hammar; A Rane
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

Review 5.  Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.

Authors:  Alan L Myers; Jitesh D Kawedia; Richard E Champlin; Mark A Kramer; Yago Nieto; Romi Ghose; Borje S Andersson
Journal:  Expert Opin Drug Metab Toxicol       Date:  2017-08-17       Impact factor: 4.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.